Fundraising Fox

PanOptica

Mt. Arlington, US · Founded 2009 · Massachusetts corporation · 3 known investors

panopticapharma.com
Biotech

Founders & leadership

PC
Paul ChaneyNamed on SEC filing
KS
Kevin StarrNamed on SEC filing
LG
Lutz GiebelNamed on SEC filing
CG
Colin GoddardNamed on SEC filing

Board

ACAbbie Celniker
Abbie CelnikerinBoard directorInvestor at Third Rock Ventures
DG
David GuyerBoard director
BP
Bruce PeacockBoard directorOperating Partner at Agent Capital

Investors · 3

Reported raises · per SEC filings

Form D private placements

$57.3M disclosed across 2 rounds · 2010–2014

$40.7MraisedApr 2019 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Abbie CelnikerDirector
  • David GuyerDirector
  • Paul ChaneyExecutive Officer, Director
  • Bruce PeacockDirector
Offering amount
$47.3M
Amount sold
$40.7M
First sale
Apr 2014
Incorporated
Corporation, Massachusetts
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$16.6MraisedMar 2012 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin StarrDirector
  • David GuyerDirector
  • Lutz GiebelDirector
  • Paul ChaneyExecutive Officer, Director
  • Colin GoddardDirector
Offering amount
$36.1M
Amount sold
$16.6M
First sale
Dec 2010
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are PanOptica's investors?
PanOptica's investors include Astellas Venture Management LLC, Agent Capital, Third Rock Ventures.
How much funding has PanOptica raised?
PanOptica has disclosed $57.3M raised across 2 rounds.
Where is PanOptica headquartered?
PanOptica is headquartered in Mt. Arlington, US.